Welcome to RPG Life Sciences – Leaders in immunosuppressants
rpgls
  • Contact Us
  • Our Story
    • History and Milestones
    • Our Brand
    • Core Strengths
    • Vision
    • Board of Directors
    • Management Team
  • Our Businesses
    • Business Portfolio
      • API
      • Domestic Formulations
      • International Formulations
      Manufacturing
      • Manufacturing Facilities
      • Quality
      Scientific Overview
      • Research and Development
      • Patents
  • Therapeutic Focus
    • Nephrology
    • Oncology
    • Urology
    • Respiratory
    • Gastrointestinal
    • Cardiovascular
    • Gynaecology and Pediatrics
    • Vitamins and Minerals
    • Pain Management
    • Neurology
    • Anti-Dengue
    • Anti-Diabetic
    • Derma
  • Life@RPGLS
    • Rewards and Recognition
      • Company Awards
      • Company Events
      • Team Awards
      • Employee Awards
      Human Resources
      • Join Us
      • Our Culture and Values
      • GPTW Award
      • Learning and Development
      EHS and CSR
      • Environment, Health and Safety
      • Corporate Social Responsibility
      Explore Us
      Happiness Matters!!
  • Investors
    • Financial Results
      • Audited Financial Results
      • Quarterly Financial Results
      Company Presentations
      • Investor Presentations
      • Corporate Presentations
      • Press Release
      Mandatory Disclosures
      • Code and Policies
      • Circulars and Disclosures
      Shareholders Information
      • Shareholding Pattern
      • Concepts and Procedure
      • Corporate Governance Reports
      • Annual Reports
      • Intimation to Stock Exchange
      • Notices of Board Meetings
      • Outcome of Board Meetings
      • AGM & Postal Ballot
      • Unpaid Dividend List
      • Newspaper Publications
      • Market tracker
      Investor Relations
      • Investor Education and Protection Fund
      • Investor Grievance
      • Investor Contacts
      • Investor Meets
      Committees Composition
      • Audit Committee
      • Risk Management Committee
      • Stakeholders Relationship Committee
      • Nomination & Remuneration Committee
      • CSR Committee
  • Media
    • Online News and Print Media

INTIMATIONS TO STOCK EXCHANGE
  • Home
  • intimations to stock exchange

Sr. No. File Name
1 Intimation of loss of share certificate December 6, 2019
2 Intimation of loss of share certificate November 28, 2019
3 Intimation of loss of share certificate October 3, 2019
4 Intimation about closing of Trading Window September 30, 2019
5 Intimation about Retirement of Director - September 24, 2019
6 Intimation of loss of share certificate September 23, 2019
7 Intimation of issue of duplicate share certificate September 19,2019
8 Intimation of issue of duplicate share certificate May 21,2019
9 Intimation of issue of duplicate share certificate february 21,2019
10 Intimation of issue of duplicate share certificate August 20,2019
11 Intimation of AGM Date and Book Closure 28.06.2019
12 Intimation of loss of share certificate June 19, 2019
13 Intimation of loss of share certificate March 8, 2019
14 Intimation of loss of share certificate February 26, 2019
15 Intimation of loss of share certificate January 29, 2019
  • 1
  • 2
  • Next

Investors Information

Company Presentations
  • Investor Presentations
  • Corporate Presentations
  • Press Release
Financial Results
  • Audited Financial Results
  • Quarterly Financial Results
  • Dividend Declarations
Investor Relations
  • Investor Education and Protection Fund
  • Investor Grievance
  • Investor Contacts
  • Investor Meets
Share Holders Information
  • Shareholding Pattern
  • Concepts and Procedure
  • Corporate Governance Reports
  • Annual Reports
  • Intimation to Stock Exchange
  • Notices of Board Meetings
  • Outcome of Board Meetings
  • AGM & Postal Ballot
  • Unpaid Dividend List
  • Newspaper Publications
  • Market tracker
Board Committees
  • Audit Committee
  • Risk Management Committee
  • Stakeholders Relationship Committee
  • Nomination & Remuneration Committee
  • CSR Committee
Mandatory Disclosures
  • Code and Policies
  • Circulars and Disclosures
Get in Touch

QUICK LINKS

Vision

Quality

History and Milestones

Company Awards

Manufacturing Facilities

Research and Development

Contact Us

  • Address(HO):
    RPG Life Sciences Limited,
    RPG HOUSE, 463, Dr. Annie Besant Road, Worli,
    Mumbai - 400030, India

  • Phone: +91 22 6660 6375 / 76 / 77

  • Fax: +91 22 2497 0127

  • Email:

Follow Us




Porto Website Template

RPG Life Sciences Limited © Copyright 2018-19. All Rights Reserved.

  • Privacy Policy
  • Sitemap
  • Contact